Arena Capital Advisors, LLC- CA - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 33 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Arena Capital Advisors, LLC- CA ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$8,894
-47.3%
111,3140.0%0.01%
+33.3%
Q4 2022$16,886
-15.6%
111,3140.0%0.01%
+50.0%
Q3 2022$20,000
+17.6%
111,3140.0%0.01%
+50.0%
Q2 2022$17,000
-58.5%
111,3140.0%0.00%
-33.3%
Q1 2022$41,000
-64.3%
111,314
-7.2%
0.01%
-45.5%
Q4 2021$115,000
+9.5%
120,0000.0%0.01%
+37.5%
Q3 2021$105,000120,0000.01%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2022
NameSharesValueWeighting ↓
Empery Asset Management, LP 40,000$46,0000.10%
ANGELO GORDON & CO., L.P. 60,000$580,0000.05%
Radcliffe Capital Management, L.P. 80,000$780,0000.02%
Anson Funds Management LP 15,000$145,0000.01%
CANTOR FITZGERALD, L. P. 162,945$156,0000.01%
Arena Capital Advisors, LLC- CA 120,000$115,0000.01%
AQR Arbitrage LLC 40,000$387,0000.01%
MMCAP International Inc. SPC 160,000$154,0000.01%
Segantii Capital Management Ltd 30,000$290,0000.01%
Atalaya Capital Management LP 100,000$96,0000.01%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders